Certified by Founder Lodge
NYBC Ventures
- ND
INVESTOR
1 Disclosed Funding Rounds $90,000,000
5 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Taking an agnostic approach to financing vehicles and structures and employing a model of patient capital, we have developed streamlined scientific and investment due diligence teams to evalu
| Company | Date | Round | Raised |
|---|---|---|---|
Star Therapeutics |
September, 05 ,2023 | Series C | $90,000,000 |
Aronora, Inc. |
October, 16 ,2023 | Unknown | |
AvenCell |
October, 22 ,2024 | Series B | $112,000,000 |
Akadeum Life Sciences, Inc. |
June, 04 ,2025 | Unknown | $20,000,000 |
Cellular Origins |
December, 17 ,2025 | Series A | $40,000,000 |
Star Therapeutics
Aronora, Inc.
AvenCell
Akadeum Life Sciences, Inc.
Cellular Origins
Xsensio
CND Life Sciences
PinkDx, Inc.
PreciseDx
Bland Company | $2,670,000 | (Feb 18, 2026)
Tangible | $4,300,000 | (Feb 18, 2026)
Helia Care, Inc. | $3,000,000 | (Feb 18, 2026)
Daffodil Health Corp | $16,300,000 | (Feb 18, 2026)
FYLD | $41,000,000 | (Feb 18, 2026)